✦ LIBER ✦

Detection of circulating anti-p53 antibodies in patients with colorectal carcinoma and the antibody's relation to clinical factors

✍ Scribed by Yutaka Shibata; Hitoshi Kotanagi; Hideaki Andoh; Kenji Koyama; Hideaki Itoh; Shin -Ei Kudo

Book ID: 112679895
Publisher: Springer
Year: 1996
Tongue: English
Weight: 652 KB
Volume: 39
Category: Article
ISSN: 0012-3706
DOI: 10.1007/bf02055121

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of circulating ant

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma

✍ Saffroy, R; Lelong, J-C; Azoulay, D; Salvucci, M; Reynes, M; Bismuth, H; Debuire 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

The detection of serum anti-p53 antibodi

The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China

✍ Lin-Lin Qiu; Pan-Yu Hua; Li-Li Ye; Yong-Cai Wang; Tian Qiu; Hui-Zheng Bao; Li Wa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Clinical significance of p53 antigen and

Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients

✍ Navapun Charuruks; Pisit Tangkijvanich; Narin Voravud; Ratana Chatsantikul; Apir 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 78 KB

The role of circulating anti-p53 antibod

The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival

✍ Michael Bergqvist; Daniel Brattström; Anders Larsson; Patrik Hesselius; Ola Brod 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 257 KB

The Presence of Serum Anti-p53 Antibodie

The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

✍ Rui-juan Gao; Hui-zheng Bao; Qiong Yang; Qi Cong; Jin-na Song; Li Wang 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 180 KB

The clinical significance of u-FCC, an a

The clinical significance of u-FCC, an antigen of anti-fucosylceramide antibody found in urine, in patients with gastric and colorectal carcinoma

✍ Takemaru Tanimizu; Hideki Ishihara; Hiroshi Hattori; Setsuo Hamada; Renzo Hiraya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

## BACKGROUND. It has already been shown that the production of fucosylceramide, an aberrant glycolipid, is associated with neoplastic changes in human tissues. The authors of this study designed a sandwich radioimmunoassay (RIA) using a mouse monoclonal anti-fucosylceramide antibody, PC47H, design